DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 123 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q2 2016. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,600 | +16.1% | 108,442 | +1.6% | 0.00% | +33.3% |
Q2 2023 | $1,378 | +26.4% | 106,712 | -4.0% | 0.00% | 0.0% |
Q1 2023 | $1,090 | -34.4% | 111,166 | -28.8% | 0.00% | -25.0% |
Q4 2022 | $1,661 | -99.9% | 156,194 | +6.2% | 0.00% | 0.0% |
Q3 2022 | $1,535,000 | +4.8% | 147,143 | +26.5% | 0.00% | 0.0% |
Q2 2022 | $1,465,000 | +2054.4% | 116,362 | +1886.4% | 0.00% | – |
Q1 2022 | $68,000 | -17.1% | 5,858 | 0.0% | 0.00% | – |
Q4 2021 | $82,000 | -27.4% | 5,858 | 0.0% | 0.00% | – |
Q3 2021 | $113,000 | +54.8% | 5,858 | -21.0% | 0.00% | – |
Q2 2021 | $73,000 | +78.0% | 7,414 | +76.1% | 0.00% | – |
Q1 2021 | $41,000 | +115.8% | 4,210 | 0.0% | 0.00% | – |
Q4 2020 | $19,000 | +5.6% | 4,210 | 0.0% | 0.00% | – |
Q3 2020 | $18,000 | -51.4% | 4,210 | 0.0% | 0.00% | – |
Q2 2020 | $37,000 | +146.7% | 4,210 | 0.0% | 0.00% | – |
Q1 2020 | $15,000 | -37.5% | 4,210 | 0.0% | 0.00% | – |
Q4 2019 | $24,000 | -22.6% | 4,210 | -46.9% | 0.00% | – |
Q2 2019 | $31,000 | -46.6% | 7,934 | 0.0% | 0.00% | – |
Q1 2019 | $58,000 | -17.1% | 7,934 | 0.0% | 0.00% | – |
Q4 2018 | $70,000 | -28.6% | 7,934 | 0.0% | 0.00% | – |
Q3 2018 | $98,000 | -19.0% | 7,934 | 0.0% | 0.00% | – |
Q2 2018 | $121,000 | -22.9% | 7,934 | 0.0% | 0.00% | – |
Q1 2018 | $157,000 | +6.1% | 7,934 | 0.0% | 0.00% | – |
Q4 2017 | $148,000 | +89.7% | 7,934 | +116.0% | 0.00% | – |
Q3 2017 | $78,000 | +122.9% | 3,673 | 0.0% | 0.00% | – |
Q2 2017 | $35,000 | +59.1% | 3,673 | 0.0% | 0.00% | – |
Q1 2017 | $22,000 | +46.7% | 3,673 | 0.0% | 0.00% | – |
Q4 2016 | $15,000 | -80.3% | 3,673 | -50.0% | 0.00% | – |
Q3 2016 | $76,000 | +43.4% | 7,346 | +100.0% | 0.00% | – |
Q2 2016 | $53,000 | -25.4% | 3,673 | 0.0% | 0.00% | – |
Q1 2016 | $71,000 | -20.2% | 3,673 | 0.0% | 0.00% | – |
Q4 2015 | $89,000 | -1.1% | 3,673 | 0.0% | 0.00% | – |
Q3 2015 | $90,000 | +4.7% | 3,673 | 0.0% | 0.00% | – |
Q2 2015 | $86,000 | +4.9% | 3,673 | 0.0% | 0.00% | – |
Q1 2015 | $82,000 | +32.3% | 3,673 | 0.0% | 0.00% | – |
Q4 2014 | $62,000 | – | 3,673 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |